Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total Cystectomy
Status:
Terminated
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess if aprotinin (BAYA0128), given intravenously during
your surgery, is safe and can help reduce the need for a blood transfusion during bladder
surgery.